EUVIMEDEUVIMED entdecken
Open Access

Synergistic Application of Mesenchymal Stem Cells and Anti‐Inflammatory Therapeutics Within Hydrogel Matrices For Enhanced Treatment of Osteoarthritis and Promotion of Cartilage Regeneration

Huajun Huang, Chunling Xiang, Hongxi Shang, Weichao Sun, Wenting Shang, Kan Chen, Jiaji Yue

Macromolecular Bioscience · 2026-07 · 26 (7)

DOI: 10.1002/mabi.70218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 13.07.2026. Verfasst von Huajun Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bone and Joint Surgery Department of Orthopedics Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China. Hauptthemen laut MEDLINE: Osteoarthritis, Mesenchymal Stem Cells, Anti-Inflammatory Agents, Hydrogels. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Team-based Medical Science Research Program, Shenzhen Second People's Hospital Clinical Research Fund of Shenzhen High-level Hospital Construction Project, Shenzhen Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is the most prevalent degenerative joint disorder, characterized by chronic joint pain, stiffness, and progressive loss of articular cartilage. To address this, the project developed an inflammatory‐targeting drug delivery system to mitigate underlying inflammation. The polyvinyl alcohol (PVA) hydrogel, a crosslinked polymer network with excellent water absorption and retention capabilities, was utilized as the drug carrier platform. The polydopamine (PDA) particles were leveraged to effectively eliminate reactive oxygen species and reduce oxidative stress. Furthermore, R‐7050, a cell‐permeable triazoline compound, was encapsulated as a TNF‐α inhibitor for targeted anti‐inflammatory therapy. To enhance therapeutic efficacy, bone marrow mesenchymal stem cells (MSCs) were incorporated into the drug delivery system, which can secrete neurotrophic factors, promote vascular regeneration, and exert superior anti‐inflammatory effects. Results have demonstrated that the developed drug delivery system (SC@PDA/PVA‐R7050 Gel) could sustain the release of therapeutic agents in the affected joint area, thereby improving the treatment efficacy. The synergistic integration of the PVA hydrogel, PDA, R‐7050, and MSCs provides a novel and promising solution for the targeted therapy of osteoarthritis, with significant clinical application potential. (177 words in total).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisMesenchymal Stem CellsAnti-Inflammatory AgentsHydrogelsRegenerationCartilage, ArticularMesenchymal Stem Cell TransplantationAnimalsPolymersIndolesHumansPolyvinyl AlcoholTriazolesDrug Delivery SystemsTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

anti‐inflammationbone marrow mesenchymal stem cellscontrolled releasehydrogelosteoarthritis

Substanzen

Anti-Inflammatory AgentsHydrogelsPolymersIndolesPolyvinyl AlcoholpolydopamineTriazolesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Bone and Joint Surgery Department of Orthopedics Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
  • Department of Interventional Radiology Suite, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
  • Department of Orthopedics, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
  • CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
  • Department of Stomatology, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.

Förderung

  • Team-based Medical Science Research Program
  • Shenzhen Second People's Hospital Clinical Research Fund of Shenzhen High-level Hospital Construction Project
  • Shenzhen Science and Technology Program
  • Guangdong Medical Science and Technology Research Foundation
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Huang, H., Xiang, C., Shang, H., Sun, W., Shang, W., Chen, K., & Yue, J. (2026). Synergistic Application of Mesenchymal Stem Cells and Anti‐Inflammatory Therapeutics Within Hydrogel Matrices For Enhanced Treatment of Osteoarthritis and Promotion of Cartilage Regeneration. Macromolecular Bioscience, 26(7). https://doi.org/10.1002/mabi.70218

Vancouver

Huang H, Xiang C, Shang H, Sun W, Shang W, Chen K, et al. Synergistic Application of Mesenchymal Stem Cells and Anti‐Inflammatory Therapeutics Within Hydrogel Matrices For Enhanced Treatment of Osteoarthritis and Promotion of Cartilage Regeneration. Macromolecular Bioscience. 2026;26(7). doi:10.1002/mabi.70218

BibTeX
@article{Huang2026,
  author = {Huang, Huajun and Xiang, Chunling and Shang, Hongxi and Sun, Weichao and Shang, Wenting and Chen, Kan and Yue, Jiaji},
  title = {Synergistic Application of Mesenchymal Stem Cells and Anti‐Inflammatory Therapeutics Within Hydrogel Matrices For Enhanced Treatment of Osteoarthritis and Promotion of Cartilage Regeneration},
  journal = {Macromolecular Bioscience},
  year = {2026},
  volume = {26},
  number = {7},
  doi = {10.1002/mabi.70218}
}
Kostenlos starten →